14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 RLMD stock ended at $3.83. This is 0.262% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 5.32% from a day low at $3.75 to a day high of $3.95.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Relmada Therapeutics, Inc. prices

Date Open High Low Close Volume
Nov 07, 2023 $3.06 $3.25 $3.01 $3.05 75 542
Nov 06, 2023 $3.14 $3.33 $3.10 $3.13 109 649
Nov 03, 2023 $3.09 $3.30 $3.09 $3.16 116 773
Nov 02, 2023 $3.00 $3.25 $2.98 $3.05 146 227
Nov 01, 2023 $3.01 $3.14 $2.95 $2.98 91 727
Oct 31, 2023 $3.02 $3.05 $2.85 $2.99 178 385
Oct 30, 2023 $2.99 $3.05 $2.99 $2.99 66 078
Oct 27, 2023 $3.12 $3.23 $2.99 $2.99 138 385
Oct 26, 2023 $3.21 $3.21 $3.06 $3.14 29 177
Oct 25, 2023 $3.04 $3.13 $3.01 $3.08 53 867
Oct 24, 2023 $3.11 $3.17 $2.98 $3.02 49 265
Oct 23, 2023 $3.00 $3.32 $2.97 $3.00 69 084
Oct 20, 2023 $3.16 $3.23 $2.95 $3.03 78 557
Oct 19, 2023 $3.44 $3.44 $3.10 $3.10 45 873
Oct 18, 2023 $3.47 $3.65 $3.39 $3.48 272 688
Oct 17, 2023 $3.22 $3.60 $3.14 $3.53 130 362
Oct 16, 2023 $3.06 $3.29 $3.04 $3.13 131 117
Oct 13, 2023 $3.18 $3.25 $3.04 $3.10 94 678
Oct 12, 2023 $3.48 $3.60 $3.15 $3.20 166 023
Oct 11, 2023 $3.29 $3.70 $3.26 $3.53 281 859
Oct 10, 2023 $3.13 $3.39 $3.11 $3.39 106 937
Oct 09, 2023 $3.04 $3.14 $3.00 $3.12 42 051
Oct 06, 2023 $3.00 $3.10 $2.92 $3.04 46 350
Oct 05, 2023 $2.99 $3.04 $2.99 $3.00 52 618
Oct 04, 2023 $3.08 $3.15 $2.95 $2.99 140 672
Click to get the best stock tips daily for free!

About Relmada Therapeutics, Inc.

Relmada Therapeutics. Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder ... RLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT